Stock listing

Munich:RER1 Recordati S.p.A. Aktie

German listing (Munich) of Recordati S.p.A. · home listing Milan:REC

Follow Recordati S.p.A. into a list and get an email when it puts out news.

Home listing price · MIL:REC

€52.75 EUR -0.05 (-0.1%)

Close on Nov 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, MIL:REC · Price from Euronext

Past month -0.4% · daily closes, Oct 28, 2026 – Nov 19, 2026, adjusted for splits
Day range
€52.75 – €52.95 EURNov 19, 2026
Volume
594,168 sharesNov 19, 2026
Market cap
€11.03B EURAt the close on Nov 19, 2026 · price × 209.1M shares outstanding
Recordati S.p.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:RICFY$14.65 USD0.00 (0.0%)230$14.65$14.65$14.65$14.65Close on Nov 20, 2026
Frankfurt:RER1€52.70 EUR-0.05 (-0.1%)—€52.55€52.75€52.55€52.75Close on Nov 19, 2026

Daily closes

Last 3 months, Oct 28, 2026 – Nov 19, 2026 · MIL:REC · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€52.75-0.05-0.1%€52.85€52.95€52.75594,168
€52.80-0.05-0.1%€52.85€52.90€52.80400,656
€52.850.000.0%€52.85€52.95€52.85438,105
€52.85+0.35+0.7%€52.90€52.95€52.85102,527
€52.50+0.05+0.1%€52.45€52.70€52.455,262,517
€52.45-0.55-1.0%€52.90€53.00€52.45213,989
€53.00-0.10-0.2%€53.05€53.15€52.75275,929
€53.10-0.15-0.3%€53.00€53.10€52.95185,374
€53.25+0.15+0.3%€53.00€53.25€52.95283,335
€53.10+0.10+0.2%€53.00€53.10€53.00378,457
€53.00+0.05+0.1%€52.95€53.05€52.95378,842
€52.95-0.05-0.1%€52.95€53.10€52.95170,870
€53.000.000.0%€53.00€53.05€52.95240,541
€53.00+0.05+0.1%€52.95€53.05€52.951,648,519
€52.95——€52.85€53.05€52.75141,771
Ticker
Munich:RER1
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Munich
Currency
EUR

What changed lately

Latest news

All Recordati S.p.A. news

Recordati S.p.A. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
12 in the last 12 months · 15 in all · newest Nov 10, 2026 · oldest 2025
Calls
22 calls with a replay · 22 with a transcript · latest Jul 29, 2026
Decks
162 decks · latest Nov 10, 2026

Where Recordati S.p.A. is listed

ListingExchangeCountryCurrency
Milan:REC · Home listingMilanItalyEUR
OTC:RICFYOTCUnited StatesUSD
gettex:RER1gettexGermanyEUR
VIE:RECViennaAustriaEUR
OTC:RCDTFOTCUnited StatesUSD
Tradegate:RER1TradegateGermanyEUR
LS Exchange:A0EABRLS ExchangeGermanyEUR
Turquoise:RECMTurquoiseUnited KingdomEUR
Lang & Schwarz:A0EABRLang & SchwarzGermanyEUR
LSIN:0KBSLSINUnited KingdomEUR
Aquis:RECMAquisUnited KingdomEUR
BMV:RECNBMVMexicoMXN
Aquis:RECMAquisUnited KingdomEUR
Stuttgart:RER1StuttgartGermanyEUR
Frankfurt:RER1FrankfurtGermanyEUR
Hanover:RER1HanoverGermanyEUR
BIVA:RECNBIVAMexicoMXN
Dusseldorf:RER1DusseldorfGermanyEUR
Hamburg:RER1HamburgGermanyEUR
Munich:RER1 · This pageMunichGermanyEUR

Team and board

Officers

OfficerRole
Robert KoremansChief Executive Officer
Mike McClellanChief Financial Officer
Bibianne BonGroup Chief Legal Officer
Silvia SignorettiGroup Corporate Law Counsel and Secretary of the Board of Directors of Recordati S.p.A
Eugenia LitzInvestor Relations
Alberto MartinezExecutive VP Specialty & Primary Care Business Unit
Alessandro GilioExecutive VP Group Industrial Operations
Gabriele FinziExecutive VP Corporate Development, Licensing & Innovation
Milan ZdravkovicExecutive VP Research & Development and Chief Medical Officer
Scott PescatoreExecutive VP Rare Diseases Business Unit
Alessandra AbateGroup Chief People and Culture Officer

Board

DirectorRole
Andrea RecordatiPresidente
Cathrin Petty
Diva MorianiIndipendente e Lid
Giampiero Mazza
Joanna Le CouilliardIndipendente
Kim Stratton
Luigi La Corte
Piergiorgio PelusoIndipendente
Robert KoremansChief Executive Officer
Stephen SandsIndipendente

Events

CallWhenStatus
Recordati (Milan:REC) Q2 2026 Earnings CallWed, Jul 29, 2026 · 8:00 AM ETReplay
Recordati (Milan:REC) Q1 2026 Earnings CallWed, May 13, 2026 · 8:00 AM ETReplay
Recordati (Milan:REC) Q4 2025 Earnings CallWed, Feb 18, 2026 · 8:00 AM ETReplay
Recordati (Milan:REC) Q3 2025 Earnings CallWed, Nov 12, 2025 · 8:00 AM ETReplay
Recordati (Milan:REC) Q2 2025 Earnings CallWed, Jul 30, 2025 · 10:00 AM ETReplay
Recordati (Milan:REC) Q3 2024 Earnings CallFri, Nov 08, 2024 · 10:00 AM ETReplay
Recordati (Milan:REC) Q2 2024 Earnings CallTue, Jul 30, 2024 · 10:00 AM ETReplay
Recordati (Milan:REC) Q3 2023 Earnings CallTue, Nov 07, 2023 · 10:00 AM ETReplay
Recordati (Milan:REC) Q2 2023 Earnings CallFri, Jul 28, 2023 · 10:00 AM ETReplay
Recordati (Milan:REC) Q1 2023 Earnings CallThu, May 11, 2023 · 11:00 AM ETReplay
All 22 calls
CallWhenStatus
Recordati (Milan:REC) Q4 2022 Earnings CallTue, Feb 21, 2023 · 10:00 AM ETReplay
Recordati (Milan:REC) Q3 2022 Earnings CallTue, Nov 08, 2022 · 10:00 AM ETReplay
Recordati (Milan:REC) Q2 2022 Earnings CallThu, Jul 28, 2022 · 10:00 AM ETReplay
Recordati (Milan:REC) Q1 2022 Earnings CallTue, May 10, 2022 · 10:00 AM ETReplay
Recordati (Milan:REC) Q4 2021 Earnings CallThu, Feb 24, 2022 · 9:00 AM ETReplay
Recordati (Milan:REC) Q3 2021 Earnings CallThu, Oct 28, 2021 · 9:00 AM ETReplay
Recordati (Milan:REC) Q2 2021 Earnings CallThu, Jul 29, 2021 · 9:00 AM ETReplay
Recordati (Milan:REC) Q1 2021 Earnings CallThu, May 06, 2021 · 9:00 AM ETReplay
Recordati (Milan:REC) Q4 2020 Earnings CallMon, Feb 22, 2021 · 10:00 AM ETReplay
Recordati (Milan:REC) Q3 2020 Earnings CallFri, Oct 30, 2020 · 11:00 AM ETReplay
Recordati (Milan:REC) Q2 2020 Earnings CallThu, Jul 30, 2020 · 10:00 AM ETReplay
Recordati (Milan:REC) Q1 2020 Earnings CallThu, May 07, 2020 · 10:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
9M 2026 Earnings PresentationEarnings17 slidesNov 10, 2026
Recordati Industria Chimica e Farmaceutica — H1 2026 Earnings PresentationEarnings22 slidesJul 29, 2026
Recordati Industria Chimica e Farmaceutica — Q1 2026 Earnings PresentationEarnings25 slidesMay 13, 2026
Recordati Industria Chimica e Farmaceutica — FY2025 Earnings PresentationEarnings25 slidesFeb 18, 2026
J.P. Morgan Healthcare Conference 2026Conference13 slidesJan 14, 2026
Recordati Industria Chimica e Farmaceutica — Q3 2025 Earnings PresentationEarnings24 slidesNov 12, 2025
Recordati Industria Chimica e Farmaceutica — H1 2025 Earnings PresentationEarnings21 slidesJul 30, 2025
Q1 2025 Earnings PresentationEarnings21 slidesMay 8, 2025
Investor Day (April 2025)Investor day45 slidesApr 29, 2025
FY2024 Earnings PresentationEarnings23 slidesFeb 13, 2025
Show 50 decks
DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2025Conference14 slidesJan 15, 2025
Recordati Industria Chimica e Farmaceutica — 9M 2024 Earnings PresentationEarnings21 slidesNov 8, 2024
Merger or Acquisition (October 2024)Merger or acquisition8 slidesOct 4, 2024
Investor Presentation (September 2024)Investor deck31 slidesSeptember 2024
Recordati Industria Chimica e Farmaceutica — H1 2024 Earnings PresentationEarnings20 slidesJul 30, 2024
Q1 2024 Earnings PresentationEarnings20 slidesMay 9, 2024
FY2023 Earnings PresentationEarnings21 slidesFeb 22, 2024
J.P. Morgan Healthcare Conference 2024Conference12 slidesJan 10, 2024
9M 2023 Earnings PresentationEarnings18 slidesNov 7, 2023
Recordati Industria Chimica e Farmaceutica — H1 2023 Earnings PresentationEarnings19 slidesJul 28, 2023
Recordati Industria Chimica e Farmaceutica — Q1 2023 Earnings PresentationEarnings19 slidesMay 11, 2023
FY2022 Earnings PresentationEarnings60 slidesFeb 21, 2023
9M 2022 Earnings PresentationEarnings16 slidesNov 8, 2022
H1 2022 Earnings PresentationEarnings18 slidesJul 28, 2022
Q1 2022 Earnings PresentationEarnings16 slidesMay 10, 2022
Recordati Industria Chimica e Farmaceutica — FY 2021 Earnings PresentationEarnings17 slidesFeb 24, 2022
Merger or Acquisition (December 2021)Merger or acquisition5 slidesDec 3, 2021
Recordati Industria Chimica e Farmaceutica — Q3 2021 Earnings PresentationEarnings14 slidesOct 28, 2021
H1 2021 Earnings PresentationEarnings14 slidesJul 29, 2021
Q1 2021 Earnings PresentationEarnings42 slidesMay 6, 2021
Recordati Industria Chimica e Farmaceutica — FY2020 Earnings PresentationEarnings14 slidesFeb 22, 2021
9M 2020 Earnings PresentationEarnings11 slidesOct 29, 2020
Merger or Acquisition (October 2020)Merger or acquisition10 slidesOct 1, 2020
Recordati Industria Chimica e Farmaceutica — H1 2020 Earnings PresentationEarnings13 slidesJul 30, 2020
Recordati Industria Chimica e Farmaceutica — Q1 2020 Earnings PresentationEarnings14 slidesMay 7, 2020
FY2019 Earnings PresentationEarnings15 slidesFeb 14, 2020
9M 2019 Earnings PresentationEarnings13 slidesOct 31, 2019
H1 2019 Earnings PresentationEarnings15 slidesJul 30, 2019
Investor Day (May 2019)Investor day37 slidesMay 9, 2019
FY2018 Earnings PresentationEarnings11 slidesFeb 11, 2019
9M 2018 Earnings PresentationEarnings11 slidesOct 30, 2018
H1 2018 Earnings PresentationEarnings11 slidesJul 26, 2018
Jefferies 2018 Global Healthcare ConferenceConference25 slidesJun 6, 2018
Q1 2018 Earnings PresentationEarnings11 slidesMay 8, 2018
FY2017 Earnings PresentationEarnings14 slidesFeb 8, 2018
Jefferies 2017 London Healthcare ConferenceConference24 slidesNov 15, 2017
9M 2017 Earnings PresentationEarnings11 slidesOct 26, 2017
Bank of America Merrill Lynch Global Healthcare Conference 2017Conference23 slidesSep 15, 2017
H1 2017 Earnings PresentationEarnings11 slidesJul 27, 2017
Jefferies Global Healthcare Conference 2017Conference23 slidesJun 8, 2017

This page holds 50 of 162 decks. Open Decks

Open Decks

Financials

Annual, in EUR

Balance sheet

LineFY2024FY2023FY2022FY2021
Cash and equivalents322.4M221.8M284.7M244.6M
Receivables361.9M307.8M
Current assets1.49B1.20B1.17B850.1M
Goodwill797.1M778.4M780.1M553.2M
Total assets5.13B4.21B4.00B2.82B
Accounts payable296.7M264.0M224.7M177.9M
Current liabilities929.1M1.00B923.7M626.4M
Shareholders' equity1.88B1.69B1.55B1.38B

Cash flow

LineFY2024FY2023FY2022FY2021
Dividends paid-130.1M-123.2M-117.2M-113.0M

Open Financials

Cap table

Built by 6ix from Recordati S.p.A.’s releases

Common shares
209,125,156
Fully diluted
209,125,156

Fully diluted

LineShares
Common shares209,125,156

Share count over time

CountShares
Nov 22, 2026209,125,156

Open Cap table

Shareholders

HolderSharesValueAs of
Strategic Advisers Fidelity International Fund1.82MUS$109MMay 31, 2026
Fidelity Series Overseas Fund1.63MUS$97.3MJul 31, 2026
Vanguard Total International Stock Index Fund1.57MUS$93.6MJul 31, 2026
Vanguard Developed Markets Index Fund1.03MUS$60.6MJun 30, 2026
iShares Core MSCI EAFE ETF825KUS$49.2MJul 31, 2026
Fidelity Overseas Fund778KUS$46.3MJul 31, 2026
Invesco International Small-Mid Company Fund650KUS$38.7MJul 31, 2026
Fidelity International Equity Central Fund641KUS$37.6MJun 30, 2026
Fidelity International Small Cap Fund597KUS$35.6MJul 31, 2026
Fidelity Mid-Cap Stock Fund597KUS$35.6MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Fidelity SAI International Low Volatility Index Fund539KUS$32.1MJul 31, 2026
Fidelity International Index Fund433KUS$26MMay 31, 2026
Fidelity Low-Priced Stock Fund401KUS$23.9MJul 31, 2026
The Continental Small Company Series399KUS$23.8MJul 31, 2026
iShares MSCI EAFE ETF397KUS$23.6MJul 31, 2026
Strategic Advisers International Fund329KUS$19.8MMay 31, 2026
Invesco Global Opportunities Fund268KUS$16MJul 31, 2026
International Core Equity 2 Portfolio259KUS$15.5MJul 31, 2026
Vanguard European Stock Index Fund254KUS$15.1MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund254KUS$15.1MJul 31, 2026
Fidelity Worldwide Fund235KUS$14MJul 31, 2026
Schwab International Equity ETF235KUS$14.1MMay 31, 2026
VIP Overseas Portfolio224KUS$13.2MJun 30, 2026
Fidelity Series Global ex U.S. Index Fund208KUS$12.4MJul 31, 2026
Fidelity Series International Small Cap Fund202KUS$12MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF186KUS$10.9MJun 30, 2026
Vanguard International Dividend Appreciation Index Fund178KUS$10.6MJul 31, 2026
Fidelity Europe Fund172KUS$10.3MJul 31, 2026
Nuveen International Equity Index Fund168KUS$10MJul 31, 2026
iShares MSCI EAFE Growth ETF162KUS$9.64MJul 31, 2026
iShares Core MSCI Total International Stock ETF154KUS$9.15MJul 31, 2026
iShares MSCI Italy ETF149KUS$8.97MMay 31, 2026
Six Circles International Unconstrained Equity Fund149KUS$8.74MJun 30, 2026
iShares MSCI Eurozone ETF139KUS$8.34MMay 31, 2026
Fidelity International Small Cap Opportunities Fund139KUS$8.27MJul 31, 2026
iShares Core MSCI International Developed Markets ETF128KUS$7.65MJul 31, 2026
Vanguard International High Dividend Yield Index Fund125KUS$7.46MJul 31, 2026
Goldman Sachs ActiveBeta(R) International Equity ETF121KUS$7.25MMay 31, 2026
Grandeur Peak Global Opportunities Fund117KUS$6.95MJul 31, 2026
Fidelity Mid-Cap Stock K6 Fund99,705US$5.94MJul 31, 2026
International Equity Index Fund96,580US$5.66MJun 30, 2026
Eaton Vance Worldwide Health Sciences Fund91,672US$5.51MMay 31, 2026
Vanguard Total World Stock Index Fund87,983US$5.24MJul 31, 2026
Multi-Manager International Equity Strategies Fund86,249US$5.18MMay 31, 2026
Six Circles Managed Equity Portfolio International Unconstrained Fund83,181US$4.88MJun 30, 2026
Aquarius International Fund78,954US$4.74MMay 31, 2026
Fidelity Low-Priced Stock K6 Fund72,395US$4.31MJul 31, 2026
Grandeur Peak Global Contrarian Fund72,216US$4.3MJul 31, 2026
JPMorgan BetaBuilders Europe ETF71,639US$4.27MJul 31, 2026
Schwab International Index Fund69,592US$4.15MJul 31, 2026

This page holds 50 of 248 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alberto MartinezExecutive VP Specialty & Primary Care Business Unit · Since at least Nov 4, 2026
Alessandra AbateGroup Chief People and Culture Officer · Since at least Nov 5, 2026
Alessandro GilioExecutive VP Group Industrial Operations · Since at least Nov 5, 2026
Andrea RecordatiPresidente · Since at least Sep 17, 2026
Bibianne BonGroup Chief Legal Officer · Since at least Nov 5, 2026
Cathrin PettyDirector · Since at least Apr 1, 2026
Diva MorianiIndipendente e Lid · Since at least Apr 1, 2026
Eugenia LitzInvestor Relations · Since at least Jul 28, 2026
Gabriele FinziExecutive VP Corporate Development, Licensing & Innovation · Since at least Nov 5, 2026
Giampiero MazzaDirector · Since at least Apr 1, 2026
All 20 people
PersonSeat
Joanna Le CouilliardIndipendente · Since at least Apr 1, 2026
Kim StrattonDirector · Since at least Apr 1, 2026
Luigi La CorteDirector · Since at least Apr 1, 2026
Mike McClellanChief Financial Officer · Since at least Oct 23, 2025
Milan ZdravkovicExecutive VP Research & Development and Chief Medical Officer · Since at least Nov 5, 2026
Piergiorgio PelusoIndipendente · Since at least Apr 1, 2026
Robert KoremansChief Executive Officer · Since at least May 14, 2026
Scott PescatoreExecutive VP Rare Diseases Business Unit · Since at least Nov 4, 2026
Silvia SignorettiGroup Corporate Law Counsel and Secretary of the Board of Directors of Recordati S.p.A · Since at least Nov 5, 2026
Stephen SandsIndipendente · Since at least Apr 1, 2026

Open People

Log in to ask 6ix AI your own questions about Recordati S.p.A.